MCU controls melanoma progression through a redox-controlled phenotype switch

Area of Science:

• Oncology
• Cell Biology
• Metabolism

Background:

• Melanoma is an aggressive skin cancer with high metastatic potential.
• Calcium signaling and metabolic pathways are implicated in melanoma invasiveness, but molecular mechanisms remain unclear.
• The mitochondrial calcium uptake (MCU) complex's role in melanoma pathobiology was previously unknown.

Purpose of the Study:

• To investigate the role of the MCU complex subunit A (MCUA) in melanoma progression and therapeutic sensitivity.
• To elucidate the molecular links between MCUA, melanoma cell phenotype, and redox regulation.

Main Methods:

• Analysis of MCUA expression in melanoma patient survival data and BRAF inhibitor-resistant melanoma.
• MCUA knockdown (KD) experiments in melanoma cell lines and xenografts.
• Proteomic analyses and protein microarrays to identify molecular pathways.
• Assessment of melanoma cell response to antioxidants, prooxidants, immunotherapies, and ferroptosis.

Main Results:

• MCUA expression inversely correlates with melanoma patient survival and is reduced in resistant melanomas.
• MCUA KD suppresses tumor growth but enhances lung metastasis in vivo.
• MCUA influences melanoma cell phenotype through redox regulation pathways.
• MCUA KD increases resistance to immunotherapies and ferroptosis.

Conclusions:

• MCUA is a key regulator of melanoma aggressiveness, metastasis, and therapeutic sensitivity.
• Targeting mitochondrial calcium and redox homeostasis may offer novel therapeutic strategies for advanced melanoma.